Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
---|
02/15/2007 | CA2618089A1 Bicyclo[2.2.]hept-7-ylamine derivatives and their uses |
02/15/2007 | CA2616428A1 Pyrazine derivatives useful as adenosine receptor antagonists |
02/15/2007 | CA2607219A1 Substituted benzimidazole compounds with dual nos inhibitory activity and mu opioid agonist activity |
02/14/2007 | EP1752458A2 Low molecular weight conjugated nitrogen compounds and devices obtainable using the same |
02/14/2007 | EP1752455A2 Chemokine receptor binding heterocyclic compounds |
02/14/2007 | EP1752452A1 Propane-1,3-dione derivative or its salt |
02/14/2007 | EP1752440A1 Amine compound having fluorene group as framework, process for producing the amine compound, and use of the amine compound |
02/14/2007 | EP1751149A1 Bicyclic-substituted amines having cyclic-substituted monocyclic substituents |
02/14/2007 | EP1751138A1 Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders |
02/14/2007 | EP1751136A2 Nitrogenated heterocyclic derivatives as protein kinase modulators and use for the treatment of angiogenesis and cancer |
02/14/2007 | EP1751130A2 Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands |
02/14/2007 | EP1751127A2 Novel cylopenta¬b|benzofuran derivatives and the utilization thereof |
02/14/2007 | EP1751124A2 Raf modulators and methods of use |
02/14/2007 | EP1751119A1 Novel fused heterocycles and uses thereof |
02/14/2007 | EP1751115A1 Theramutein modulators |
02/14/2007 | EP1751113A1 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
02/14/2007 | EP1751103A1 4-(5-(aminomethyl)-indole-1-ylmethyl)-benzamide derivatives and related compounds as opioid receptor antagonists for the treatment of obesity |
02/14/2007 | EP1750706A1 Dual small molecule inhibitors of cancer and angiogenesis |
02/14/2007 | EP1750704A2 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
02/14/2007 | EP1750698A2 5-anilino-4-heteroarylpyrazole derivatives useful for the treatment of diabetes |
02/14/2007 | EP1651640B1 Nicotinamide derivatives useful as pde4 inhibitors |
02/14/2007 | EP1534391B1 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders |
02/14/2007 | EP1395554B1 Substituted carbazoles as inhibitors of spla2 |
02/14/2007 | EP1370552B1 Rho-kinase inhibitors |
02/14/2007 | EP1368336B9 Thiophene substituted amine derivatives as glyt-1 inhibitors |
02/14/2007 | EP1345928B1 Pyrazole compounds useful as protein kinase inhibitors |
02/14/2007 | EP1343757B1 Indole derivatives |
02/14/2007 | EP1296961B1 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists |
02/14/2007 | EP1063982B1 Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders |
02/14/2007 | CN1914509A Time-temperature indicator based on valence isomerizations |
02/14/2007 | CN1914224A HCV NS-3 serine protease inhibitors |
02/14/2007 | CN1914173A Quinolines useful in treating cardiovascular disease |
02/14/2007 | CN1913895A Novel M3 muscarinic acetylcholine receptor antagonists |
02/14/2007 | CN1913886A 杂环天冬氨酰蛋白酶抑制剂 Heterocyclic aspartyl protease inhibitors |
02/14/2007 | CN1913884A Substituted benzazoles and methods of their use as inhibitors of RAF kinase |
02/14/2007 | CN1911930A Chemokine receptor anagonists, methods and use therefor |
02/14/2007 | CN1911913A New neuropeptide YY5 receptor antagonists |
02/14/2007 | CN1300114C Phenylpyridine carbonyl piperazine derivative |
02/14/2007 | CN1300110C Hydroxamate derives useful as deacetylase inhibitors |
02/13/2007 | US7176320 Benzimidazole derivative |
02/13/2007 | US7176316 Amino-piperidine derivatives |
02/13/2007 | US7176242 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives |
02/13/2007 | US7176236 Water-soluble etoposide analogs and methods of use thereof |
02/13/2007 | US7176229 Pyrrolidine antiinflammatory agents for rheumatoid arthritis, osteoarthritis; antiallergens for asthma, chronic bronchitis, allergic rhinitis, adult respiratory distress syndrome, chronic pulmonary inflammatory disease; reduce or eliminate adverse CNS side effects associated with prior PDE4 inhibitors |
02/13/2007 | US7176220 Useful as an anti-HIV agent that particularly shows an anti-HIV action based on an integrase inhibitory activity; for treatment or prophylaxis of AIDS; for example, 6-(2,3-dichlorobenzyl)-1-(2-hydroxyethyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
02/13/2007 | US7176213 For example, 1-(9-benzylamino-10-cyano-imidazo[1,2-a]quinolin-2-carbonyl)pyrrolidine; may be used for the treatment of diseases such as asthma, glaucoma, tumors, allergic and inflammatory diseases, ischemia, hypoxia, arrythmia and renal diseases |
02/13/2007 | US7176208 Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors |
02/13/2007 | US7176207 Anticoagulants; antithrombotic agents in the treatment and prevention of thrombosis |
02/13/2007 | US7176201 Modulation of anxiety through blockade of anandamide hydrolysis |
02/13/2007 | US7176200 Derivatives of sulphonamides, their preparation and use as medicaments |
02/13/2007 | CA2285037C Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same |
02/13/2007 | CA2220649C 4-hydroxy-piperidine derivatives |
02/13/2007 | CA2122236C Quinolines and their analogs |
02/08/2007 | WO2007016292A2 Heterocyclic amides as biofilm modulators |
02/08/2007 | WO2007015744A1 Disubstituted thienyl compounds and their use as pharmaceuticals |
02/08/2007 | WO2007015412A1 Heterocyclic compound and organic electroluminescent device using same |
02/08/2007 | WO2007014619A1 Novelimidazolecarboxamide derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same |
02/08/2007 | WO2006126171A3 New antibiotic derivatives |
02/08/2007 | US20070032653 N-{1-(4-(3-bromophenyl)-1H-imidazol-2-yl)-5-methylhexyl}-N-cyclohexylamine; agonists or antagonists of somatostatin receptors; acromegaly, restenosis, Crohn's disease, systemic sclerosis, external and internal pancreatic pseudocysts and ascites, nesidoblastosis, hyperinsulinism, gastrinoma, etc. |
02/08/2007 | US20070032541 monocyte chemotactic proteins (MCP)-1 receptor antagonist or agonist; 2-{1-[(1,2-cis)-2-(4-Methylsulfanyl-benzoylamino)-cyclohexyl]-2-oxo-pyrrolidin-3-ylcarbamoyl}-4-trifluoromethyl-phenyl)-carbamic acid tert-butyl ester; antiinflammatory agent, antiallergen; asthma, rheumatoid arthritis, atherosclerosis |
02/08/2007 | US20070032526 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents |
02/08/2007 | US20070032525 e.g. (1H-benzoimidazol-2-yl)-[1-(3,4-dichloro-benzyl)-piperidin-4-ylmethyl]-amine; chemokine (C-C motif) receptor antagonist; antiallergen; asthma and allergic rhinitis, atopic dermatitis, urticaria, contact dermatitis, alleriric coniunctivitis, inflammatory bowel disease, AIDS, eosinqphilia |
02/08/2007 | US20070032523 Chemical compounds |
02/08/2007 | US20070032520 Indol-5-yl sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
02/08/2007 | US20070032518 Compounds and methods of use |
02/08/2007 | US20070032497 Fused-ring compounds and use thereof as drugs |
02/08/2007 | US20070032490 N-Phenyl-'(4-pyridyl)-azinyl!amine derivatives as plant protection agents |
02/08/2007 | US20070032489 Substituted pyridones as inhibitors of poly(adp-ribose) polymerase (parp) |
02/08/2007 | US20070032434 Novel compounds as inhibitors of hepatitis C virus NS3 serine protease |
02/08/2007 | CA2617282A1 Novel imidazolecarboxamide derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same |
02/08/2007 | CA2616510A1 Cycloalkyl amino-hydantoin compounds and use thereof for .beta.-secretase modulation |
02/07/2007 | EP1749165A2 Threaded connection for oil field applications |
02/07/2007 | EP1749001A1 3-piperidinylisochroman-5-ols as dopamine agonists |
02/07/2007 | EP1749000A2 Bicyclic, substituted triazoles as modulators of ppar and methods of their preparation |
02/07/2007 | EP1748997A1 Substituted thiophene-2-carboxylic acid amides, the production thereof and the use thereof as drugs |
02/07/2007 | EP1748996A1 Substituted thiophen-carboxylic acid amides, the production and the use thereof in the form of a drug |
02/07/2007 | EP1748991A1 Morpholinylanilinoquinazo- line derivatives for use as antiviral agents |
02/07/2007 | EP1748987A2 2-propene-1-ones as hsp 70 inducers |
02/07/2007 | EP1748984A1 Piperidine derivatives as nk1 and nk3 antagonists |
02/07/2007 | EP1748983A2 Compounds as inhibitors of hepatitis c virus ns3 serine protease |
02/07/2007 | EP1748982A1 (4, 5, 6, 7-tetrahydro-1-h-indol-7-yl) acetic acid derivatives for treatment of alzheimer's disease |
02/07/2007 | EP1748980A1 Pyrrolidine derivatives as cb1-receptor antagonists |
02/07/2007 | EP1606255A4 Cyclic derivatives as modulators of chemokine receptor activity |
02/07/2007 | EP1421079B1 Thiophenyl compounds as medicaments |
02/07/2007 | CN1910172A 3-(dihydro(tetrahydro)isoquinolin-1-yl)quinolines |
02/07/2007 | CN1910158A Heterocyclic sulfonamide inhibitors of beta amyloid production containing an azole |
02/07/2007 | CN1910157A Derivatives of N'- (1,5-diphenyl-1H-pyrazol-3-yl) sulphonamide with CBI receptor affinity |
02/07/2007 | CN1910151A Cyclic amine derivative with heteroaryl ring |
02/07/2007 | CN1909907A Quinoline derivatives and use thereof as mycobacterial inhibitors |
02/07/2007 | CN1908113A Organic electroluminescent blue-light five-membered heterocycle distyrene compound |
02/07/2007 | CN1907970A Method for synthesizing heteroaryl thiosemicarbazone antineoplastic |
02/07/2007 | CN1907968A Method for making 4-(3,4-dichlorophenoxy)piperidine |
02/07/2007 | CN1298715C Non-imidazole compounds as histamine H3 antagonists |
02/07/2007 | CN1298704C Isatine derivatives with neurotrophic activity |
02/06/2007 | US7173134 retinoid X receptors ("RXRs"); useful for the treatment of diabetes (NIDDIM) and obesity; for example, 3-{4-[(5,5,8,8-Tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)methyl]-2-furyl}-2-propenoic acid |
02/06/2007 | US7173132 Certain substituted 1-aryl-3-piperazine-1′-yl propanones |
02/06/2007 | US7173131 Anthryl derivative group substituted compound, and organic luminescent device making use of same |
02/06/2007 | US7173129 Sulfonamide-substituted chalcone derivatives and their use to treat diseases |
02/06/2007 | US7173060 Antitumor agents, anticarcinogenic agents; inhibitors of histone deacetylase; a methyleneaminooxymethyl)-thiophene-2-carboxylic acid (2-amino-phenyl)-amide derivatives; chemical synthesis |
02/06/2007 | US7173048 Indolyl derivatives as liver-X-receptor (LXR) modulators |